These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

8049 related articles for article (PubMed ID: 14708716)

  • 41. Molecular and immunologic aspects of the nonclassical HLA class I antigen HLA-G: evidence for an important role in the maternal tolerance of the fetal allograft.
    Moreau P; Paul P; Rouas-Freiss N; Kirszenbaum M; Dausset J; Carosella ED
    Am J Reprod Immunol; 1998 Sep; 40(3):136-44. PubMed ID: 9764357
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of HLA-G in human mononuclear phagocytes and selective induction by IFN-gamma.
    Yang Y; Chu W; Geraghty DE; Hunt JS
    J Immunol; 1996 Jun; 156(11):4224-31. PubMed ID: 8666791
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Progress of HLA-G in cancer.
    Carosella ED; Dausset J
    Semin Cancer Biol; 2003 Oct; 13(5):315-6. PubMed ID: 14708710
    [No Abstract]   [Full Text] [Related]  

  • 44. Functional up-regulation of human leukocyte antigen class I antigens expression by 5-aza-2'-deoxycytidine in cutaneous melanoma: immunotherapeutic implications.
    Fonsatti E; Nicolay HJ; Sigalotti L; Calabrò L; Pezzani L; Colizzi F; Altomonte M; Guidoboni M; Marincola FM; Maio M
    Clin Cancer Res; 2007 Jun; 13(11):3333-8. PubMed ID: 17545540
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of classic and nonclassic HLA class I antigens in uveal melanoma.
    Anastassiou G; Rebmann V; Wagner S; Bornfeld N; Grosse-Wilde H
    Invest Ophthalmol Vis Sci; 2003 May; 44(5):2016-9. PubMed ID: 12714638
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Soluble human leukocyte antigen--G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy.
    Ugurel S; Rebmann V; Ferrone S; Tilgen W; Grosse-Wilde H; Reinhold U
    Cancer; 2001 Jul; 92(2):369-76. PubMed ID: 11466692
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HLA-G gene repression is reversed by demethylation.
    Moreau P; Mouillot G; Rousseau P; Marcou C; Dausset J; Carosella ED
    Proc Natl Acad Sci U S A; 2003 Feb; 100(3):1191-6. PubMed ID: 12552087
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Patterns of constitutive and IFN-gamma inducible expression of HLA class II molecules in human melanoma cell lines.
    Rodríguez T; Méndez R; Del Campo A; Aptsiauri N; Martín J; Orozco G; Pawelec G; Schadendorf D; Ruiz-Cabello F; Garrido F
    Immunogenetics; 2007 Feb; 59(2):123-33. PubMed ID: 17180681
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of HLA-G expression in breast cancer tissues.
    Palmisano GL; Pistillo MP; Fardin P; Capanni P; Nicolò G; Salvi S; Spina B; Pasciucco G; Ferrara GB
    Hum Immunol; 2002 Nov; 63(11):969-76. PubMed ID: 12392849
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MHC antigens in human melanomas.
    Ruiter DJ; Mattijssen V; Broecker EB; Ferrone S
    Semin Cancer Biol; 1991 Feb; 2(1):35-45. PubMed ID: 1912517
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HLA expression in uveal melanoma: there is no rule without some exception.
    Jager MJ; Hurks HM; Levitskaya J; Kiessling R
    Hum Immunol; 2002 Jun; 63(6):444-51. PubMed ID: 12039519
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Leukemia inhibitory factor (LIF) stimulates the human HLA-G promoter in JEG3 choriocarcinoma cells.
    Bamberger AM; Jenatschke S; Schulte HM; Löning T; Bamberger MC
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3932-6. PubMed ID: 11061559
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of HLA-G expression in malignant hematopoetic cells from leukemia patients.
    Poláková K; Krcová M; Kuba D; Russ G
    Leuk Res; 2003 Jul; 27(7):643-8. PubMed ID: 12681364
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exosomes bearing HLA-G are released by melanoma cells.
    Riteau B; Faure F; Menier C; Viel S; Carosella ED; Amigorena S; Rouas-Freiss N
    Hum Immunol; 2003 Nov; 64(11):1064-72. PubMed ID: 14602237
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Complexes of HLA-G protein on the cell surface are important for leukocyte Ig-like receptor-1 function.
    Gonen-Gross T; Achdout H; Gazit R; Hanna J; Mizrahi S; Markel G; Goldman-Wohl D; Yagel S; Horejsí V; Levy O; Baniyash M; Mandelboim O
    J Immunol; 2003 Aug; 171(3):1343-51. PubMed ID: 12874224
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of recombinant human leukocyte, fibroblast, and immune interferons on expression of class I and II major histocompatibility complex and invariant chain in early passage human melanoma cells.
    Nisticò P; Tecce R; Giacomini P; Cavallari A; D'Agnano I; Fisher PB; Natali PG
    Cancer Res; 1990 Dec; 50(23):7422-9. PubMed ID: 1701342
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Total loss of HLA class I expression on a melanoma cell line after growth in nude mice in absence of autologous antitumor immune response.
    Paco L; Garcia-Lora AM; Casares C; Cabrera C; Algarra I; Collado A; Maleno I; Garrido F; Lopez-Nevot MA
    Int J Cancer; 2007 Nov; 121(9):2023-2030. PubMed ID: 17621628
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Blastocyst MHC, a putative murine homologue of HLA-G, protects TAP-deficient tumor cells from natural killer cell-mediated rejection in vivo.
    Tajima A; Tanaka T; Ebata T; Takeda K; Kawasaki A; Kelly JM; Darcy PK; Vance RE; Raulet DH; Kinoshita K; Okumura K; Smyth MJ; Yagita H
    J Immunol; 2003 Aug; 171(4):1715-21. PubMed ID: 12902470
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Suppression of class I human histocompatibility leukocyte antigen by c-myc is locus specific.
    Versteeg R; Krüse-Wolters KM; Plomp AC; van Leeuwen A; Stam NJ; Ploegh HL; Ruiter DJ; Schrier PI
    J Exp Med; 1989 Sep; 170(3):621-35. PubMed ID: 2788705
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential modulation by tumor necrosis factor and immune interferon of HLA class-II antigens expressed by melanoma cells.
    Maio M; Gulwani B; Morgano A; Ferrone S
    Int J Cancer; 1989 Sep; 44(3):554-9. PubMed ID: 2506138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 403.